CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- SB-2/A Other SB-2/A
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Unregistered share sale
- S-1 Offering Registration Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Material agreement
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 10QSB Other 10QSB
- 8-K Event Material agreement
- 8-K Event Delisting notice
- 8-K Event Results of operations
Page 59 of 72 · 1,429 filings